AI Article Synopsis

  • The study focused on the patterns of circulating microparticles (MPs) in type 2 diabetes patients who have asymptomatic atherosclerosis.
  • A total of 103 T2DM patients and 35 healthy volunteers were analyzed to compare the levels and types of MPs, revealing that T2DM patients had specific MP variations linked to atherosclerosis.
  • Key findings indicated that certain factors like BMI, LDL cholesterol, and specific types of MPs were independent predictors of asymptomatic atherosclerosis in T2DM patients.

Article Abstract

Background: Accelerating atherosclerosis in type 2 diabetes mellitus (T2DM) patients may relate to imbalance between pattern of microparticles (MPs), which are frequently involved in repair of vasculature, tissue injury, inflammation and thrombosis. The aim of the study was to investigate the pattern of circulating MPs in T2DM patients with asymptomatic atherosclerosis.

Methods: A total of 103 patients with T2DM (54 subjects without documented coronary atherosclerosis and 49 patients with angiographic evidence of asymptomatic coronary atherosclerosis) who were underwent a contrast-enhanced multispiral computed tomography angiography and 35 healthy volunteers were enrolled in the study. To determine circulating biomarkers, blood samples were collected at baseline. MPs were labelled and characterized by flow cytometry.

Results: There were no significant differences between healthy volunteers and T2DM patients in circulating numbers of MPs labelled as CD41a+, CD64+, CD144+, CD144+/CD31+, Annexin V+, CD144+/annexin V+ and CD144+/CD31+/annexin V+. However, lower number of MPs with immune phenotypes CD62E+, CD105E+ and higher numbers of CD31+/annexin V+ MPs were reported in T2DM patients when compared with healthy volunteers. Therefore, we found an increased level of circulating CD41a+ MPs, CD144+/CD31+ MPs, CD31+/annexin V+ MPs, and decreased level of CD62E+ MPs in T2DM patients with asymptomatic coronary atherosclerosis in comparison with those who had no asymptomatic atherosclerosis. Using multivariate log regression analysis, BMI (odds ratio [OR] = 1.04, p = 0.001), LDL-C (OR = 1.05, p = 0.046), hs-CRP (OR = 1.07, p = 0.044), osteoprotegerin (OR = 1.07, p = 0.026), CD62E+ MPs (OR = 1.07, p = 0.001) and CD31+/annexin V+ MPs (OR = 1.12, p = 0.003) were determined independent predictive factors of asymptomatic atherosclerosis in T2DM patients.

Conclusion: Circulating levels of MP originated from apoptotic endothelial cell-derived were significantly increased in diabetic patients as compared with normal subjects, but level of activated endothelial cell-derived MPs was lower than in healthy volunteers. Among T2DM patients, an increased level of CD31+/annexin V+ MPs and decreased CD62E+ MPs were significantly associated with asymptomatic atherosclerosis.

Download full-text PDF

Source
http://dx.doi.org/10.1080/17843286.2015.1110894DOI Listing

Publication Analysis

Top Keywords

t2dm patients
24
asymptomatic atherosclerosis
16
healthy volunteers
16
cd31+/annexin mps
16
mps
15
coronary atherosclerosis
12
cd62e+ mps
12
patients
10
pattern circulating
8
diabetes mellitus
8

Similar Publications

Background: Complications of diabetes and its associated comorbidities can cause rapid progression of type II diabetes mellitus (T2DM). It comes at high costs and affects a patient's quality of life. We aim to assess T2DM in KSA, including the demographics, medications, complications, and comorbidities, as it remains an integral part of Vision 2030.

View Article and Find Full Text PDF

Background Type 2 diabetes mellitus (T2DM) is associated with a high risk of developing microvascular complications such as diabetic nephropathy, diabetic neuropathy (DN), and diabetic retinopathy (DR), leading to significant morbidity. Early detection of these complications is crucial for improving patient outcomes. Neutrophil-lymphocyte ratio (NLR) and urine albumin-creatinine ratio (UACR) show promise as cost-effective and accessible biomarkers for the early detection of microvascular complications in T2DM.

View Article and Find Full Text PDF

Background: Salivary compounds can be used as diagnostic markers for changes in the oral cavity that cause oral problems in type 2 diabetes mellitus (T2DM).

Methods: This meta-analysis searched PubMed/Medline, EMBASE, Scopus and Cochrane Library, and the Web of Science until Nov 2023. The observational studies included patients with T2DM and healthy controls aged > 18 yr with no oral health problems or systematic or periodontal diseases.

View Article and Find Full Text PDF
Article Synopsis
  • Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic condition in Saudi Arabia, and while bariatric surgery is known to aid in weight loss and potentially induce remission, long-term effects specific to the Saudi population are not well understood.
  • A retrospective study analyzed medical records of 74 Saudi adults who underwent bariatric surgery from 2016-2020, focusing on changes in Hemoglobin A1c (HbA1c) levels pre-and post-surgery and evaluating diabetes remission based on American Diabetes Association criteria.
  • Results showed significant improvements in glycemic control, with mean HbA1c levels dropping from 8.70 to 6.76 after one year; however, only 27%
View Article and Find Full Text PDF

Objectives: Glucagon-like peptide 1 (GLP-1) receptor agonists have recently proven to be an effective treatment for type 2 diabetes mellitus (T2DM). However, these drugs are also known to carry a significant risk of drug-induced pancreatitis. The purpose of this study is to determine whether or not GLP-1-associated pancreatitis risk is dose-dependent.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!